Homogeneous multiwell assays for measuring cell viability, cytotoxicity, and apoptosis

Handbook of Assay Development in Drug Discovery

Volumn , Issue , 2006, Pages 385-406

  Riss, Terry L ^a   Moravec, Richard A ^a   O'Brien, Martha A ^a   Hawkins, Erika M ^a   Niles, Andrew ^a  

^a PROMEGA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650469961     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (18)

1. Riss T, Moravec R. Simplifying cytotoxicity screening: introducing the CellTiter-Blue™ cell viability assay. Promega Notes 2003; 83:10-13.
2. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65:55-63.
3. Barltrop JA, Owen TC. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tet-razolium, inner salt (MTS), and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg Med Chem Lett 1991; 1:611-614.
4. 3H]thymidine incorporation assays. J Immunol Meth 1994; 170:211-224.
5. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Meth 1983; 64:313-320.
6. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Meth 1988; 115:61-69.
7. Riss T, Moravec R. Introducing the CytoTox-ONE™ Homogeneous Membrane Integrity Assay. Promega Notes 2002; 82:15-18.
8. Riss T, Moravec R. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2004; 2(1):51-62.
9. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Meth 1993; 160:81-88.
10. Kangas L, Grönoos M, Nieminen A-L. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 1984; 62:338-343.
11. Lundin, A, Hasenson M, Persson J, and Pousette A. Estimation of biomass in growing cell lines by ATP assay. Meth Enzymol 1986; 133:27-42.
12. Sevin BU, Peng ZL, Perras JP, Ganjei P, Penalver M, Averette HE. Application of an ATP bioluminescence assay in human tumour chemosensitivity testing. Gyn Oncol 1988; 31:191-204.
13. Hall MP, Gruber MG, Hannah RR, Jennens-Clough ML, Wood KV. Stabilization of firefly luciferase using directed evolution. In: Roda A, Pazzagli M, Kricka LJ, Stanley PE, Eds. Bioluminescence and Chemiluminescence - Perspectives for the 21st Century. Chichester, U.K.: John Wiley & Sons, 1998:392-395.
14. ™ luminescent cell viability assay: a sensitive and rapid method for determining cell viability. Cell Notes 2001; 2:11-13.
15. Moravec R, Beck M, Hannah R. High-throughput screening with the CellTiter-Glo™ luminescent cell viability assay. Cell Notes 2001; 2:14-16.
16. ™ nonradioactive cytotoxicity assay. Promega Notes 1994; 45:11-12.
17. Humpal-Winter J, Niles A, d Bjerke M. Apo-ONE™ homogeneous caspase-3/7 assay: rapid apoptosis detection in high-throughput applications. Promega Notes 2001; 79:33-35.
18. O'Brien M, Moravec R, Riss T. Caspase-Glo™ 3/7 Assay: use fewer cells and spend less time with this homogeneous assay. Cell Notes 2003; 6:13-15.